Hanan Goldberg on Twitter: "PSA doubling time does not have a linear correlation with high risk nmCRPC disease... Dr. Sartor at #NSAUA @urotoday https://t.co/A99tm3XAQo" / Twitter
Correlation of Initial PSA Level and Biopsy Features with PSA-Doubling Time in Early Stage Prostate Cancers in Japanese Men
Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
GitHub - conan-koh123/Calculating-PSA-Doubling-Time-for-many-patients: R code to calculate PSA doubling time (in months) for many patients
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging - ScienceDirect
Kaplan-Meier Analysis of PSA Doubling Time. Freedom from biochemical... | Download Scientific Diagram
PDF] Implications of prostate-specific antigen doubling time as indicator of failure after surgery or radiation therapy for prostate cancer. | Semantic Scholar
Practical rules for calculating PSA doubling time
PSA- Calculations of Doubling - Apps on Google Play
PSA (prostataspezifisches Antigen): Tumormarker des Prostatakarzinoms
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy - ScienceDirect
Understand PSA Doubling Time | Ask a Prostate Expert, Mark Scholz, MD - YouTube
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Cancers | Free Full-Text | Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel
PDF] Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | Semantic Scholar
Shorter PSA Doubling Time Predicts Worse Outcomes in nmCRPC - Renal and Urology News